Literature DB >> 4539012

Regulation of lymphocyte responses in vitro: potentiation and inhibition of rat lymphocyte responses to antigen and mitogens by cytochalasin B.

M Yoshinaga, A Yoshinaga, B H Waksman.   

Abstract

Cytochalasin B, at concentration between 0.02 and 0.2 mug/ml, was slightly stimulatory to lymph-node cells from normal rats and greatly potentiated their response to phytohemagglutinin and low concentrations of concanavalin A (mitogens for thymus-derived lymphocytes); it also potentiated the response of thymocytes to phytohemagglutinin. The response of lymphnode cells to lipopolysaccharide endotoxin (a mitogen for thymus-independent lymphocytes) was also enhanced, but only at concentrations in the usual inhibitory range, possibly by inhibition of a "suppressor T-cell" response. Sensitized lymphocytes responding to antigen were not stimulated at all, except at a very high cell density, where inhibition of a "suppressor cell" response was also considered likely. At concentrations of 5-10 mug/ml or higher, cytochalasin B inhibited all responses tested.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4539012      PMCID: PMC389747          DOI: 10.1073/pnas.69.11.3251

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Cytochalasin B: does it affect actin-like filaments?

Authors:  A Forer; J Emmersen; O Behnke
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

Review 2.  The function of the delayed sensitivity reaction as revealed in the graft reaction culture.

Authors:  H Ginsburg
Journal:  Adv Cancer Res       Date:  1970       Impact factor: 6.242

3.  The thymus and circulating lymphocytes of mice.

Authors:  M J Doenhoff; A J Davies; E Leuchars; V Wallis
Journal:  Proc R Soc Lond B Biol Sci       Date:  1970-10-13

4.  Cytochalasin B. 3. Inhibition of human polymorphonuclear leukocyte phagocytosis.

Authors:  A T Davis; R Estensen; P G Quie
Journal:  Proc Soc Exp Biol Med       Date:  1971-05

5.  The effect of PHA, PPD, allogeneic cells, and sheep erythrocytes on albumin gradient-fractionated mouse spleen cell populations.

Authors:  W H Adler; D Peavy; R T Smith
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

6.  The occurrence of two types of cytotoxic lymphoid cells in mice immunised with allogeneic tumour cells.

Authors:  S Denham; C K Grant; J G Hall; P Alexander
Journal:  Transplantation       Date:  1970-04       Impact factor: 4.939

7.  Microfilaments in cellular and developmental processes.

Authors:  N K Wessells; B S Spooner; J F Ash; M O Bradley; M A Luduena; E L Taylor; J T Wrenn; K Yamada
Journal:  Science       Date:  1971-01-15       Impact factor: 47.728

8.  Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens.

Authors:  G Janossy; M F Greaves
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

9.  Effects of cytochalasins on mammalian cells.

Authors:  S B Carter
Journal:  Nature       Date:  1967-01-21       Impact factor: 49.962

10.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  6 in total

1.  Patterns of B-lymphocyte gene expression elicited by lipopolysaccharide mitogen.

Authors:  G Janossy; J Snajdr; M Simak-Ellis
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

2.  Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

3.  Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes.

Authors:  R M Syme; J C Spurrell; L L Ma; F H Green; C H Mody
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

4.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression.

Authors:  D A Cheresh; D H Haynes; J A Distasio
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

5.  Cellular requirements for the formation of EA rosettes by human monocytes.

Authors:  J H Passwell; E Schneeberger; E Merler
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

6.  Cytochalasin B is a potent mitogen for chronic lymphocytic leukemia cells in vitro.

Authors:  R A Larson; S Yachnin
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.